The many reasons a person may sleepwalk include genetics, sleep deprivation, stress, migraines, fever, breathing disorders, ...

RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, ...

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...

GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American ...

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

Global High Throughput Screening Market is valued approximately at USD 19.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.70% over the forecast period 2024-2032.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8530 ...

The 2024 The Canadian Society of Clinical Perfusion (CSCP) Team Award has been awarded to the perfusionists at the McGill University Health Center (MUHC). This prestigious recognition honors their ...

Circulatory death livers preserved for donation with normothermic machine perfusion had the lowest early allograft dysfunction rate. This method led to the shortest hospital and ICU lengths of stay.

Here, we identified a circuit, locus coeruleus descending noradrenergic neurons projecting to the spinal dorsal horn (LC →SDH -NA neurons), that is activated by acute exposure to restraint stress and ...

The global perfusion imaging market is on a trajectory of robust growth, with market revenues expected to rise from USD 2,421.4 million in 2024 to nearly USD 3,382.8 million by 2034. According to a ...